187 related articles for article (PubMed ID: 37892425)
1. How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
Bzdęga W; Kurzyna PF; Harasim-Symbor E; Hołownia A; Chabowski A; Konstantynowicz-Nowicka K
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892425
[TBL] [Abstract][Full Text] [Related]
2. The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.
Charytoniuk T; Iłowska N; Berk K; Drygalski K; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Jan; 217():1-7. PubMed ID: 30468835
[TBL] [Abstract][Full Text] [Related]
3. Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity.
Bielawiec P; Harasim-Symbor E; Konstantynowicz-Nowicka K; Sztolsztener K; Chabowski A
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32859125
[TBL] [Abstract][Full Text] [Related]
4. Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.
Sztolsztener K; Konstantynowicz-Nowicka K; Harasim-Symbor E; Chabowski A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830360
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes.
Zywno H; Bzdega W; Kolakowski A; Kurzyna P; Harasim-Symbor E; Sztolsztener K; Chabowski A; Konstantynowicz-Nowicka K
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33673122
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol - A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance.
Charytoniuk T; Sztolsztener K; Harasim-Symbor E; Berk K; Chabowski A; Konstantynowicz-Nowicka K
Biomed Pharmacother; 2021 Oct; 142():112057. PubMed ID: 34435590
[TBL] [Abstract][Full Text] [Related]
8. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway.
Kołakowski A; Kurzyna PF; Żywno H; Bzdęga W; Harasim-Symbor E; Chabowski A; Konstantynowicz-Nowicka K
Molecules; 2021 Jun; 26(11):. PubMed ID: 34204938
[TBL] [Abstract][Full Text] [Related]
10. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
11. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.
Roszczyc-Owsiejczuk K; Zabielski P
Front Endocrinol (Lausanne); 2021; 12():635175. PubMed ID: 33815291
[TBL] [Abstract][Full Text] [Related]
13. Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts.
Mastrocola R; Dal Bello F; Cento AS; Gaens K; Collotta D; Aragno M; Medana C; Collino M; Wouters K; Schalkwijk CG
Free Radic Biol Med; 2021 Jun; 169():425-435. PubMed ID: 33905864
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid metabolism in non-alcoholic fatty liver diseases.
Régnier M; Polizzi A; Guillou H; Loiseau N
Biochimie; 2019 Apr; 159():9-22. PubMed ID: 30071259
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity.
Charytoniuk T; Sztolsztener K; Bielawiec P; Chabowski A; Konstantynowicz-Nowicka K; Harasim-Symbor E
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216351
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.
Garbowska M; Łukaszuk B; Mikłosz A; Wróblewski I; Kurek K; Ostrowska L; Chabowski A; Żendzian-Piotrowska M; Zalewska A
J Cell Physiol; 2017 Oct; 232(10):2766-2775. PubMed ID: 28369933
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity.
Hodun K; Sztolsztener K; Chabowski A
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684414
[TBL] [Abstract][Full Text] [Related]
18. Disrupted sphingolipid metabolism following acute clozapine and olanzapine administration.
Weston-Green K; Babic I; de Santis M; Pan B; Montgomery MK; Mitchell T; Huang XF; Nealon J
J Biomed Sci; 2018 May; 25(1):40. PubMed ID: 29720183
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.
Blachnio-Zabielska AU; Koutsari C; Tchkonia T; Jensen MD
Obesity (Silver Spring); 2012 Dec; 20(12):2341-7. PubMed ID: 22677645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
